e-Drug3D

1402

EFLORNITHINE


INN
EFLORNITHINE

cas 70052-12-9
CLASS

DERMATOLOGICALS
INHIBITOR OF ORNITHINE DECARBOXYLASE (ODC)
REDUCTION OF UNWANTED FACIAL HAIR IN WOMEN
ANTIPARASITIC

ROUTE (list)

INJECTION TOPICAL ORAL

ATC code

D11AX16
L01XX79
P01CX03

PK parameters

t1/2 8 HOUR

Target

TARGET ORNITHINE DECARBOXYLASE (ODC)

PDB
3GN0 (CRYSTAL STRUCTURE OF HUMAN ARGINASE I IN COMPLEX WITH DIFLUOROMETHYLORNITHINE (DFMO))

Ligand code = DMO (link to the list of PDB complexes)

Download experimental 3D coordinates of DMO with added hydrogens

DrugCentral

Ornithine decarboxylase UNIPROT P11926 ODC1

Ornithine decarboxylase UNIPROT Q9TZZ6

Download SDF file 2,5-diamino-2-(difluoromethyl)pentanoic acid

Formula:
C6H12F2N2O2

Calculated chemical properties:

MW 181.17
NB_atoms 12
XLogP -1.56
PSA 83.106
NB_HD 4
NB_HA 4
fsp3 0.83
Lipinski(0=no;1=yes) 1

FDA
NDA 019879 (pdf not found) INN (EFLORNITHINE HYDROCHLORIDE) ORNIDYL (SANOFI AVENTIS US) APPROVAL= AP YEAR= 1990 NEWMOLECULARENTITY DISCONTINUED
NDA 021145 (pdf not found) INN (EFLORNITHINE HYDROCHLORIDE) VANIQA (ABBVIE) APPROVAL= AP YEAR= 2000 DISCONTINUED
NDA 215500 (pdf not found) INN (EFLORNITHINE HYDROCHLORIDE) IWILFIN (USWM) APPROVAL= AP YEAR= 2023

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL